• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 4. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

Introduction to 1-(3-bromopyridin-4-yl)ethan-1-one (CAS No. 111043-06-2)

1-(3-bromopyridin-4-yl)ethan-1-one, identified by its Chemical Abstracts Service (CAS) number 111043-06-2, is a significant compound in the realm of pharmaceutical and chemical research. This organometallic derivative features a pyridine core substituted with a bromine atom at the 3-position and an acetyl group at the 1-position, making it a versatile intermediate in synthetic chemistry. The structural motif of this compound has garnered attention due to its potential applications in drug discovery, particularly in the development of novel bioactive molecules.

The pyridine ring is a privileged scaffold in medicinal chemistry, known for its ability to interact with biological targets such as enzymes and receptors. The introduction of a bromine atom at the 3-position enhances the electrophilicity of the ring, facilitating further functionalization through cross-coupling reactions. This property makes 1-(3-bromopyridin-4-yl)ethan-1-one a valuable building block for constructing more complex molecules. Additionally, the acetyl group at the 1-position provides a site for further derivatization, enabling the synthesis of diverse pharmacophores.

In recent years, there has been growing interest in developing small-molecule inhibitors targeting protein-protein interactions (PPIs), which play crucial roles in various diseases, including cancer and inflammation. The bromopyridine moiety in 1-(3-bromopyridin-4-yl)ethan-1-one has been explored as a key structural element in designing PPI modulators. For instance, studies have demonstrated that bromopyridines can act as scaffolds for binding to specific pockets on protein surfaces, thereby disrupting aberrant interactions that contribute to disease pathogenesis.

One of the most notable applications of 1-(3-bromopyridin-4-yl)ethan-1-one is in the synthesis of kinase inhibitors. Kinases are enzymes that phosphorylate other proteins, regulating a wide range of cellular processes. Dysregulation of kinase activity is implicated in numerous diseases, making them attractive therapeutic targets. The bromo-substituted pyridine group allows for efficient coupling with nitrogen-containing heterocycles via Suzuki-Miyaura or Buchwald-Hartwig cross-coupling reactions, leading to the generation of potent kinase inhibitors. These inhibitors have shown promise in preclinical studies for their ability to modulate signaling pathways involved in cancer progression.

Moreover, the acetyl group in 1-(3-bromopyridin-4-yl)ethan-1-one can be further functionalized to introduce additional pharmacological properties. For example, acetylation can enhance solubility or modify binding affinity to biological targets. This flexibility makes the compound a valuable tool for medicinal chemists seeking to optimize drug-like properties such as bioavailability, metabolic stability, and target engagement.

Recent advancements in computational chemistry have also highlighted the potential of 1-(3-bromopyridin-4-yl)ethan-1-one as a lead compound for virtual screening. High-throughput virtual screening (HTVS) combined with molecular docking techniques has enabled researchers to rapidly identify novel drug candidates. The unique structural features of this compound make it an attractive starting point for generating libraries of derivatives with enhanced biological activity. By leveraging computational methods, scientists can predict binding affinities and optimize interactions with therapeutic targets, streamlining the drug discovery process.

The synthesis of 1-(3-bromopyridin-4-yl)ethan-1-one typically involves multi-step organic transformations starting from commercially available precursors such as 4-bromoacetophenone and 3-bromopyridine. The bromine atom at the 3-position of the pyridine ring is crucial for subsequent cross-coupling reactions, which are often catalyzed by palladium complexes. These reactions provide access to a wide range of substituted pyridines with potential therapeutic applications. The efficiency and scalability of these synthetic routes are essential for large-scale production required for pharmaceutical development.

In conclusion, 1-(3-bromopyridin-4-yl)ethan-1-one (CAS No. 111043-06-2) represents a promising compound in medicinal chemistry due to its versatile structural features and potential applications in drug discovery. Its role as an intermediate in synthesizing kinase inhibitors and PPI modulators underscores its importance in addressing critical biological targets associated with human diseases. As research continues to uncover new therapeutic strategies, compounds like 1-(3-bromopyridin-4-yl)ethan-1-one will remain at the forefront of innovation, driving advancements in chemical biology and pharmaceutical science.

• 70201-42-2(3,5-Dibromopyridine-4-carbaldehyde)
• 70201-43-3(3-bromopyridine-4-carbaldehyde)
• 1019877-23-6((2-Bromophenyl)-(pyridin-4-yl)-methanone)
• 870244-29-4(1-(3,5-dibroMopyridin-4-yl)ethanone)
• 1245915-91-6(1-(5-Bromo-2-chloropyridin-4-yl)ethanone)
• 864851-69-4(Ethanone, 1-(3-bromophenyl)-2-(3-bromo-4-pyridinyl)-)
• 1187669-54-0(2-bromo-1-(3-bromopyridin-4-yl)ethan-1-one hydrobromide)
• 1261557-66-7(4-(5-Amino-2-bromobenzoyl)pyridine)
• 359018-64-7((3-bromo-4-pyridinyl)-3-pyridinyl-methanone,)
• 1449008-16-5(3-bromopyridine-4-carbaldehyde;hydrochloride)